Long-term effects of ezetimibe + statin (atorvastatin or rosuvastatin) combination therapy and double-dose statin therapy on low-density lipoprotein cholesterol in patients with coronary artery disease and hyperlipidaemia refractory to standard therapy

Trial Profile

Long-term effects of ezetimibe + statin (atorvastatin or rosuvastatin) combination therapy and double-dose statin therapy on low-density lipoprotein cholesterol in patients with coronary artery disease and hyperlipidaemia refractory to standard therapy

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Nov 2012

At a glance

  • Drugs Ezetimibe (Primary) ; Atorvastatin; Rosuvastatin
  • Indications Coronary artery disease; Hyperlipidaemia
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 26 Nov 2012 New trial record
    • 07 Nov 2012 Results presented at the 85th Annual Scientific Sessions of the American Heart Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top